Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$127.16

-2.32 (-1.79%)

07:24
08/14/18
08/14
07:24
08/14/18
07:24

Sarepta Therapeutics initiated with a Buy at Citi

Citi analyst Joel Beatty initiated coverage of Sarepta Therapeutics with a Buy rating and $174 price target. The analyst sees $35 of share upside for Sarepta before the end of 2019 from its gene therapy platform. Gene therapy is the most promising therapeutic modality in late-stage development for Duchenne muscular dystrophy and likely to be approved, Beatty tells investors in a research note. He believes Sarepta's transition to gene therapy is likely to be successful.

SRPT Sarepta
$127.16

-2.32 (-1.79%)

08/01/18
08/01/18
UPGRADE
Target $163

Overweight
Sarepta upgraded to Overweight after recent pullback at Morgan Stanley
As previously reported, Morgan Stanley analyst Matthew Harrison upgraded Sarepta Therapeutics to Overweight from Equal Weight, noting that the stock is down about 34% since June 19 after having moved up by about 50% when its initial DMD gene therapy data was announced. He sees the pullback as an opportunity to own the stock near pre-DMD gene therapy levels without taking the binary risk, Harrison tells investors. He we doesn't think a major bear case has emerged on the prospects for the company's DMD gene therapy program and he sees major catalysts in the second half of this year that he believes the market is missing. Harrison has a $163 price target on Sarepta shares, which closed yesterday at $116.24.
08/01/18
08/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoZone (AZO) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker saying Improving comps and fundamentals, coupled with a stock that has underperformed year-to-date, has brought a "compelling" valuation. 2. Pandora (P) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying the company's double-digit organic revenue growth and declining EBITDA losses were driven by improving execution, adding that while the 2% active listener hours decline is a worry, the valuation on the stock is "undemanding" given its expected annualized revenue growth of about 10% over the next 3 years. 3. Papa John's (PZZA) upgraded to Buy from Hold at Jefferies with analyst Alexander Slagle saying the stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving. 4. Electronic Arts (EA) upgraded to Buy from Hold at Argus with analyst Joseph Bonner saying the latest pullback in the stock price after the company's recent Q1 earnings report offers a favorable entry point. 5. Sarepta (SRPT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying the stock is down about 34% since June 19 after having moved up by about 50% when its initial DMD gene therapy data was announced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/18
08/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JEFFERIES UPGRADES DROPBOX TO BUY: Jefferies analyst John DiFucci upgraded Dropbox (DBX) to Buy from Hold with an unchanged price target of $32. The analyst is not making a call on the Q2 results, which come on August 9. Rather, the upgrade is based "entirely on valuation," he stated. Dropbox is up 4.7% in late morning trading. JEFFERIES UPGRADES PAPA JOHN'S: Jefferies analyst Alexander Slagle upgraded Papa John's (PZZA) to Buy from Hold and raised his price target for the shares to $58 from $52. The stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving, Slagle said. After reviewing the company's potential path to recovery and possible strategic actions that could create shareholder value, the analyst has a bull case of $75 per share. He thinks this outweighs the bear case, or downside risk, of $35 per share. SAREPTA UPGRADED AFTER PULLBACK: Morgan Stanley analyst Matthew Harrison upgraded Sarepta Therapeutics (SRPT) to Overweight from Equal Weight, noting that the stock has given up much of the gains it saw when its initial DMD gene therapy data was announced. He sees the pullback as an opportunity to own the stock near pre-DMD gene therapy levels without taking the binary risk. He doesn't think a major bear case has emerged on the prospects for the company's DMD gene therapy program and he sees major catalysts in the second half of this year that he believes the market is missing. Harrison has a $163 price target on Sarepta shares. PIPER CUTS SHOPIFY TO NEUTRAL: Piper Jaffray analyst Michael Olson downgraded Shopify (SHOP) to Neutral from Overweight and lowered his price target to $145 from $155, saying that Shopify's Q2 was "good, but not good enough" with monthly recurring revenue below investor expectations. While Olson said Shopify is performing well, he believes their performance is mostly reflected in the stock's current valuation. PIPER RECOMMENDS BIOGEN AFTER MANAGEMENT MEETING: After hosting investor meetings with Biogen (BIIB) investor relations this week, Piper Jaffray analyst Christopher Raymond came away feeling like the "all-important" high-dose APOE4 subset analysis of the BAN2401 results "may be provided sooner than later." If shown to have little impact on the overall placebo-adjusted ADCOMS benefit, this should be an important event, Raymond said. Coupling this with "continued solid commercial momentum and a host of other value-enhancing catalysts," the analyst continues to like the risk/reward on Biogen. He kept an Overweight rating on shares with a $400 price target.
08/09/18
BARD
08/09/18
NO CHANGE
Target $202
BARD
Outperform
Sarepta designated as Fresh Pick at Baird
Baird analyst Brian Skorney designated Sarepta as a Fresh Pic following Q2 results which showed Exondys 51 sales coming in ahead of expectations, an acceleration of casimersen towards a 2019 NDA filing, and an expansion of its gene therapy platform. The analyst believes Sarepta shares are poised to start a climb back up following the recent pullback in the stock. Skorney reiterated his Outperform rating and $202 price target on Sarepta.

TODAY'S FREE FLY STORIES

GILD

Gilead

$64.12

1.3 (2.07%)

07:58
04/26/19
04/26
07:58
04/26/19
07:58
Initiation
Gilead initiated  »

Gilead initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

SBUX

Starbucks

$77.07

0.65 (0.85%)

07:57
04/26/19
04/26
07:57
04/26/19
07:57
Recommendations
Starbucks analyst commentary  »

Starbucks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$137.30

2.2 (1.63%)

, CMCSA

Comcast

$42.95

1.08 (2.58%)

07:55
04/26/19
04/26
07:55
04/26/19
07:55
Periodicals
AI startup named Humu tries to block Hulu from brand confusion suit, WSJ says »

Over-the-top streaming…

DIS

Disney

$137.30

2.2 (1.63%)

CMCSA

Comcast

$42.95

1.08 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 08

    May

GPI

Group 1 Automotive

$76.26

1.59 (2.13%)

07:52
04/26/19
04/26
07:52
04/26/19
07:52
Downgrade
Group 1 Automotive rating change  »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 13

    Nov

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:50
04/26/19
04/26
07:50
04/26/19
07:50
Recommendations
Amazon.com analyst commentary at Oppenheimer »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

INTC

Intel

$57.59

-1.13 (-1.92%)

07:49
04/26/19
04/26
07:49
04/26/19
07:49
Recommendations
Intel analyst commentary at Morgan Stanley »

Morgan Stanley still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 16

    May

  • 03

    Jun

  • 25

    Jul

BC

Brunswick

$48.51

-6.01 (-11.02%)

07:48
04/26/19
04/26
07:48
04/26/19
07:48
Recommendations
Brunswick analyst commentary at SunTrust »

Brunswick price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

BMRN

BioMarin

$85.40

-0.06 (-0.07%)

07:48
04/26/19
04/26
07:48
04/26/19
07:48
Recommendations
BioMarin analyst commentary at Cantor Fitzgerald »

Cantor continues to see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:47
04/26/19
04/26
07:47
04/26/19
07:47
Recommendations
Amazon.com analyst commentary at Credit Suisse »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

DOW

Dow Inc.

$55.33

-0.67 (-1.20%)

07:47
04/26/19
04/26
07:47
04/26/19
07:47
Initiation
Dow Inc. initiated  »

Dow Inc. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 29

    May

MMM

3M

$190.67

-28.57 (-13.03%)

07:46
04/26/19
04/26
07:46
04/26/19
07:46
Downgrade
3M rating change  »

3M downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 18

    May

  • 29

    May

WING

Wingstop

$77.85

0.03 (0.04%)

07:46
04/26/19
04/26
07:46
04/26/19
07:46
Hot Stocks
Wingstop launches delivery in Dallas as part of national rollout with DoorDash »

Wingstop has officially…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

07:45
04/26/19
04/26
07:45
04/26/19
07:45
General news
Treasury Market Outlook: bond yields richened overnight »

Treasury Market Outlook:…

RGEN

Repligen

$57.24

1.04 (1.85%)

07:44
04/26/19
04/26
07:44
04/26/19
07:44
Hot Stocks
Repligen to acquire C Technologies for $240M in cash, stock »

Repligen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 28

    May

  • 13

    Nov

ADS

Alliance Data

$153.85

-9.69 (-5.93%)

07:44
04/26/19
04/26
07:44
04/26/19
07:44
Recommendations
Alliance Data analyst commentary at BMO Capital »

Alliance Data price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

CLF

Cleveland-Cliffs

$9.71

0.19 (2.00%)

07:44
04/26/19
04/26
07:44
04/26/19
07:44
Upgrade
Cleveland-Cliffs rating change  »

Cleveland-Cliffs upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOCA

Tocagen

$9.13

0.63 (7.41%)

07:44
04/26/19
04/26
07:44
04/26/19
07:44
Initiation
Tocagen initiated  »

Cantor starts Tocagen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TILE

Interface

$15.67

-1.44 (-8.42%)

07:41
04/26/19
04/26
07:41
04/26/19
07:41
Hot Stocks
Interface Chief Accounting Officer put on administrative leave amid SEC probe »

Interface received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    May

AMZN

Amazon.com

$1,902.53

1.81 (0.10%)

07:41
04/26/19
04/26
07:41
04/26/19
07:41
Recommendations
Amazon.com analyst commentary at KeyBanc »

Amazon's 1-day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 22

    May

  • 03

    Jun

INTC

Intel

$57.59

-1.13 (-1.92%)

07:41
04/26/19
04/26
07:41
04/26/19
07:41
Recommendations
Intel analyst commentary at Credit Suisse »

Intel structural thesis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 16

    May

  • 03

    Jun

  • 25

    Jul

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:40
04/26/19
04/26
07:40
04/26/19
07:40
Hot Stocks
American Airlines sees Q2 TRASM up 1%-3% y/y »

The company also expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

AAL

American Airlines

$33.36

-0.64 (-1.88%)

07:40
04/26/19
04/26
07:40
04/26/19
07:40
Hot Stocks
American Airlines reports Q1 PRASM up 0.6% »

Passenger demand drove a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 21

    May

  • 29

    May

  • 12

    Jun

07:40
04/26/19
04/26
07:40
04/26/19
07:40
General news
Oil Action: WTI crude »

Oil Action: WTI crude has…

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

, S

Sprint

$5.61

-0.01 (-0.18%)

07:39
04/26/19
04/26
07:39
04/26/19
07:39
Recommendations
T-Mobile, Sprint analyst commentary  »

T-Mobile price target…

TMUS

T-Mobile

$72.68

-0.67 (-0.91%)

S

Sprint

$5.61

-0.01 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

07:38
04/26/19
04/26
07:38
04/26/19
07:38
Conference/Events
The National Press Club to host a luncheon meeting »

Panera Bread Founder…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.